Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fortress Biotech, Inc. | 163,877 | reported | 21 Sept 2021 | tx 4+2,297−77,112 |
| TENAX THERAPEUTICS, INC. | 30,000 | reported | 09 Jan 2026 | tx 4+216,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jan 2026 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 01 Jul 2025 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 80,000 | 0.00 USD | deriv |
| 10 Dec 2024 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 100,000 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 6,250 | 0.00 USD | deriv |
| 21 Sept 2021 | SALE | Fortress Biotech, Inc. | 28,292 | 3.13 USD | |
| 22 Sept 2020 | SALE | Fortress Biotech, Inc. | 28,450 | 4.38 USD | |
| 03 Jun 2019 | PURCHASE | Fortress Biotech, Inc. | 2,297 | 1.10 USD | |
| 23 Nov 2018 | SALE | Fortress Biotech, Inc. | 20,370 | 1.29 USD |